In recent years, monoclonal antibodies have emerged as an increasingly important class of
human therapeutics. A variety of forms of antibodies, including fragments such as Fabs …

With 18 monoclonal antibody (mAb) products currently on the market and more than 100 in
clinical trials, it is clear that engineered antibodies have come of age as biopharmaceuticals …

Whole antibody molecules and their constituent fragments such as Fab and F (ab') 2 are in
widespread use as clinical and research reagents. In addition, these molecules either alone …

At present, single-chain variable fragments (scFv) of antibodies are considered one of the
most important tools in human therapies. Wide applications of antibodies are being …

Development trends for therapeutic antibody fragments | Nature Biotechnology Skip to main
content Thank you for visiting nature.com. You are using a browser version with limited support …

Antibody fragments are used in the clinic as important therapeutic proteins for treatment of
indications where better tissue penetration and less immunogenic molecules are needed …

Recombinant antibodies are now very important in both therapeutics and diagnostics and
offer significant advantages over conventional antibodies. The generation of a single-chain …

Antibody-based therapeutics are currently being tested in an increasingly diverse range of
therapeutic modalities. Many different engineered formats for the antibody molecule and …

Monoclonal antibodies (mAbs) have proven to be useful for development of new therapeutic
drugs and diagnostic techniques. To overcome the difficulties posed by their complex …

Recombinant antibody technology is opening new perspectives for the development of
novel therapeutic and diagnostic agents. In this review we focus on advances in the …